“This is the first time I have seen a bottle like this,” said Yu, a 37-year-old Chinese-born nurse who lives in San Francisco.
The color is different, but it’s the same color.”
The bottle is the latest example of the rising popularity of Chinese medicine in the United States, which is seeing a rise in Chinese tourists visiting its beaches and parks.
“Chinese medicine is here to stay in America, and there is no better way to do that than to travel,” said Tom Shulman, a health economist at the American Enterprise Institute.
While there are no official statistics on the number of Chinese tourists, Shulmans research shows that the Chinese population in the U.S. is expected to grow by 3.3 million people over the next five years, making it the third-largest foreign tourist market in the country.
In 2020, Chinese tourists to the U:ll spend $7.4 billion.
The number of Americans visiting China, however, is expected only to increase by 0.5% in 2020, Shunmans said.
While Chinese medicine has become more popular in recent years, the popularity of the drug has been growing more slowly.
According to Shulmen, the number one reason for this is the cost of importing Chinese medicine.
“When Chinese medicine is available, you can buy it cheaper than American medicine,” he said.
According to Shunman, one of the reasons for this trend is that the U,S.
has a strict tax code.
“We have a different way of paying taxes and we have a way of processing payments,” he explained.
“You can’t do it in the Chinese system, which has its own problems with paperwork.”
A lack of clarity around Chinese tax laws has also made it difficult for Americans to determine whether a Chinese company that supplies their medicine is legitimate.
Many of the products being marketed to American patients are not registered with the Internal Revenue Service.
In the past, American patients have filed complaints with the IRS, and the agency has taken action against a number of the companies that were implicated in scams in China.
The FDA is also looking into the legality of Chinese medications being sold in the states.
“There’s a lot of confusion,” said FDA spokesperson Jennifer Cavanaugh.
“I think it’s important that we continue to look into this as a matter of public health and as a way to make sure that American consumers have the information that they need.”